Chembio Diagnostics Inc (CEMI)

[trendzone]

US Prez speech just now said he will require that a lot more people will have to get rapid COVID 19 testing at work if they don't get vaccinated, and more testing in general, that could be a big boost for this stock tomorrow and squeeze the 10% of the float that's short, and who knows how many naked shorted shares are out there that corrupt MM's and hedge funds are holding, that could spark a big ugly red short squeeze for shorts.

[BottomBounce]

Chembio $CEMI To Ship $4M Of WHO-Qualified HIV Test Kits To Ethiopia In 2022

[BottomBounce]

$CEMI U.S. Deaths From Coronavirus Surpass 650,000

[BottomBounce]

Chembio $CEMI recently launched a rapid test, cleared for emergency use by the FDA, that can differentiate between #COVID19 and #influenza Type A and Type B.

[ttottip]

Today will be a great day!

[ttottip]

Our patience will pay off soon.

[BottomBounce]

$CEMI launched commercial distribution of SCOV-2 Ag Detect Rapid Test, a third party COVID-19 antigen assay.

[BottomBounce]

$CEMI $8.00 upgrade. 12-month price forecasts for Chembio Diagnostics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +198.51% increase from the last price of 2.68. https://money.cnn.com/quote/forecast/forecast.html?symb=cemi

[BottomBounce]

$CEMI Covid19 Testing https://money.cnn.com/quote/forecast/forecast.html?symb=cemi

[BottomBounce]

$CEMI Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, Hepatitis C, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, Rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.

[BottomBounce]

loading dips

[ttottip]

Ready to explode?

[ttottip]

Churning, churning $$$$$$$$$$$$

[ttottip]

Just patience! CEMI is on the verge of the short squeeze.

[OneDay4488]

Agree

[BottomBounce]

$CEMI $8.00 12-month price forecasts for Chembio Diagnostics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +191.97% increase from the last price of 2.74.

[ttottip]

This will explode at any moment! The short squeeze is imminent!

[BottomBounce]

$CEMI Chembio Diagnostics FDA Emergency Use Nod For Its Partner's LumiraDX COVID-19 Antibody Test

[OneDay4488]

Great news but seem to be unable to hold runs. We are overdue for a break out. I’m locked and loaded for $5 plus

[BottomBounce]

*** Covid19 $CEMI to launch of commercial distribution of SCOV-2 Ag Detect Rapid Test, a third party COVID-19 antigen assay.

[ttottip]

Soon this is going to move up.

[BottomBounce]

$CEMI 12-month price forecasts for Chembio Diagnostics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +178.75% increase from the last price of 2.87.

[BottomBounce]

Filled gap

[oxnous]

CEMI chart

[OneDay4488]

Bought more today

[BottomBounce]

$CEMI The FDA granted emergency use authorization to Chembio Diagnostics Inc's (NASDAQ: CEMI) COVID-19 antibody test.
The nod comes for LumiraDx SARS-CoV-2 Ab Test, a microfluidic immunofluorescence assay for the qualitative detection of total antibodies in whole human blood, plasma, or serum for indication of recent or prior infection.
Recently, the Company received a $28 million order to supply DPP SARS-CoV-2 Antigen tests for delivery during 2021 in Brazil.

[powerbattles]

$CEMI Super low floaters with the right news it can get there in one day.

[BottomBounce]

$CEMI $8.00 upgrade 12-month price forecasts for Chembio Diagnostics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +174.44% increase from the last price of 2.92. https://money.cnn.com/quote/forecast/forecast.html?symb=cemi

[barnyarddog]

The SCoV-2 Ag Detect™ Rapid Test, manufactured by InBios International, Inc., is a rapid immunoassay test authorized for use in laboratories with a CLIA waiver certification. It provides results in 20 minutes from a nasal swab and requires no instrumentation. The test can be used for both patients who are suspected of COVID-19 by their healthcare provider within 5 days of symptom onset and for asymptomatic serial testing.

August 27, 2021, 8:00 AM
https://finance.yahoo.com/news/chembio-launches-commercial-distribution-third-120000414.html

CEMI
Chembio Diagnostics, Inc.
2.9300 +0.2400
+8.9219%

[BottomBounce]

$CEMI U.S. COVID-19 hospitalizations hit 100,000 to mark highest level since January

[BottomBounce]

$CEMI Here it is Covid19 MAP Worldwide

https://coronavirus.jhu.edu/map.html

[BottomBounce]

$10 coming

[beambe]

NEWS

[trendzone]

Big news out 10% of the float short just waiting to get squeezed through the roof.

[makinbacon1]

awesome they pulled back up after hours. I honestly got a strong feeling it's just one little thing that makes this thing pass the 3 dollar range. Hopefully that one little thing is a blockbuster pr about a fda approval about a vaccination

[BUFCARP]

Explode time !

[BottomBounce]

$CEMI 12-month price forecasts for Chembio Diagnostics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +198.51% increase from the last price of 2.68. https://money.cnn.com/quote/forecast/forecast.html?symb=CEMI

[BottomBounce]

$CEMI The FDA has granted emergency use authorization to Chembio Diagnostics Inc's (NASDAQ:CEMI partner LumiraDx's COVID-19 antibody test.
LumiraDx and Chembio had announced a partnership on March 12, 2020 to develop point of care COVID-19 antibody test.
The nod comes for LumiraDx SARS-CoV-2 Ab Test, a microfluidic immunofluorescence assay for the qualitative detection of total antibodies in whole human blood, plasma, or serum for indication of recent or prior infection.
Recently, the Company received a $28 million order to supply DPP SARS-CoV-2 Antigen tests for delivery during 2021 in Brazil.


https://www.benzinga.com/trading-ideas/long-ideas/21/08/22306248/chembio-diagnostics-stock-is-trading-higher-on-fda-emergency-use-nod-for-its-partners-lu

[BottomBounce]

$CEMI COVID19 on FDA approval Emergency Use on Antibody Test $CEMI Chembio Diagnostics On FDA Emergency Use Nod For Its COVID-19 Antibody Test

https://www.benzinga.com/trading-ideas/long-ideas/21/08/22306248/chembio-diagnostics-stock-is-trading-higher-on-fda-emergency-use-nod-for-its-partners-lu

[powerbattles]

Long Island-based Chembio, a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, respiratory and insect vector diseases, will be holding a Job Fair on Sat., Aug. 28 from 9 a.m. to 2 p.m. at the company’s 3661 Horseblock Road, Medford facility.

The company is growing rapidly and has over 100 job openings. New staff is needed as the company scales up manufacturing to meet already existing orders for its infectious disease tests. Multiple manufacturing, quality and scientific positions are available and employment opportunities include full benefits, $16-$35 per hour wages, $2,000 sign-on bonuses and other financial incentives.
https://tbrnewsmedia.com/chembio-in-medford-holds-job-fair-aug-28/

[powerbattles]

As Delta Variant Surges, So Does Demand for At-Home Covid-19 Tests
https://www.wsj.com/articles/delta-variant-home-covid-tests-11629918580?st=u9oyp0slmwi4zxt&reflink=article_copyURL_share

[BottomBounce]

$CEMI Chembio To Ship $4M Of WHO-Qualified HIV Test Kits To Ethiopia In 2022.
HIV Diagnostics Market Revenue to Cross USD $760 Mn by 2027: Global Market Insights Inc.

[BottomBounce]

Chembio $CEMI recently launched a rapid test, cleared for emergency use by the FDA, that can differentiate between #COVID19 and #influenza Type A and Type B.

[BUFCARP]

Looks bullish hoping to get threes soon !

[BUFCARP]

Still keeps churning up .. looking for more contract news! Cemi$$$$

[makinbacon1]

Get me back to my 3.08. There seems to be a little uptick going on here. I got 2300 shares and I'm holding to 5 bucks minimal. Hoping for a fda approval on one of there tests or applications to the fda approval and we would fly like jeff bezos rocket. Waiting i think is worth it here

[BUFCARP]

It’s getting ready to go again .. bet we get some more contracts.. Cemi $$$$$

[makinbacon1]

Would be so nice to see cemi make a good end of month run. I got 2300 at a average of 3.08. So little baby stock Jesus help me thank you. Amen

[BUFCARP]

Yep price creeping up looks ready to go !

[BottomBounce]

$CEMI MACD Bullish Crossover